(Q84697215)
Statements
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison (English)
INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-µg Doses with COPD Patients) study investigators
O. Kornmann
R. Dahl
A. Dogra
R. Owen
C. Lassen